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Obstructive sleep apnoea is a common condition associated with 
significant morbidity and increased mortality. During sleep, the sub 
atmospheric pressure developed in the extra thoracic airway by the 
contraction of the thoracic pump muscles during inspiration causes 
collapse of the compliant upper airway, resulting in an episode of 
apnoea. Normally, upper airway collapse is prevented by contraction 
of upper airway muscles and if the airway does collapse, it is re-opened 
by a reflex augmented neural drive and greater contraction of these 
muscles. Therefore, the function of these muscles plays a critical role in 
the pathogenesis of the obstructive sleep apnoea. The multiple episodes 
of apnoea that occur during the course of sleep cause intermittent 
hypoxia. We have proposed that chronic intermittent hypoxia causes 
adverse changes in structure and function of upper airway muscle that 
result in an exacerbation of the condition. We have shown that chronic 
intermittent hypoxia in rats causes greater fatigability of upper airway, 
diaphragm and limb muscles. In general, this appears to be true also 
for chronic continuous hypoxia, although the diaphragm muscle is 
relatively tolerant of sustained hypoxia compared to limb muscle. We 
propose that the chronic intermittent hypoxia of obstructive sleep 
apnoea causes a positive feedback that exacerbates the condition by 
reducing upper airway muscle endurance, thus making the upper 
airway more vulnerable to collapse. This effect involves the generation of 
reactive oxygen species and treatment with antioxidants either prevents 
or ameliorates the adverse effects on muscle function, suggesting that 
antioxidants could be used as an adjunct therapy for obstructive sleep 
apnoea. This may be true also for respiratory disease in general since 
chronic continuous hypoxia is also associated with increased muscle 
fatigue.
Obstructive sleep apnoea (OSA) is a common respiratory disorder 
[1]. Its effects on health are widespread, including deleterious 
effects on cardiovascular, respiratory, endocrine, muscle, brain and 
haematological function [2]. In OSA, the upper airway collapses 
during inspiration, during sleep causing apnoea. Normally, collapse is 
prevented by contraction of a large number of upper airway muscles 
that stiffen and/or dilate the airway and when the airway does collapse, 
it is the contraction of these muscles that re-opens the airway [3]. 
Although the causes of OSA are multifactorial, the function of these 
upper airway muscles plays a crucial role in the pathogenesis of the 
condition, hence the importance of studies aimed at understanding 
their anatomy, physiology and pathophysiology. 
During the episodes of obstruction, the levels of oxygen in the 
arterial blood decreases and when the airway re-opens, the hypoxia is 
alleviated. Therefore, OSA is associated with intermittent hypoxia or 
asphyxia, the combination of hypoxia and hypercapnia (raised carbon 
dioxide levels). Some of our work has focussed on the hypothesis that 
intermittent hypoxia and asphyxia adversely affect upper airway muscle 
function, thereby creating a vicious cycle that makes the condition 
worse. This hypothesis was developed based on the fact that upper 
airway muscle morphology was reported to be abnormal in the English 
bulldog, an animal model of sleep apnoea [4] and in OSA patients [5]. 
It was also based on the knowledge that chronic continuous hypoxia 
can affect skeletal muscle structure and function so it occurred to us 
that perhaps the changes in upper airway muscle structure observed 
in humans and dogs with OSA were an effect rather than a cause of the 
condition i.e. that perhaps intermittent hypoxia and/or asphyxia cause 
changes in upper airway muscle structure and therefore in function. 
We have tested this hypothesis by using a rat model of OSA whereby 
the animal is exposed to cycles of changing inspired oxygen or oxygen 
and carbon dioxide levels for 8 hours per day for several days or weeks 
in order to mimic the chronic intermittent hypoxia and asphyxia of 
human OSA. What we found was that chronic intermittent hypoxia 
and asphyxia did indeed affect upper airway muscle morphology 
and physiology. However, the effects on structure were minor but 
there was a consistent increase in muscle fatigability [6,7] and this 
was also true for limb muscles and for the diaphragm muscle [8]. 
More recently, we have identified a slow to fast fibre type transition 
(that favours increased fatigability) in diaphragm muscle following 
chronic intermittent hypoxia treatment [9]. Somewhat similar findings 
have been also reported elsewhere [10] and our data are further 
corroborated by the reported effects of chronic continuous hypoxia 
which, although to some extent equivocal, appear to be broadly similar. 
Thus, the chronic sustained hypoxia of chronic obstructive pulmonary 
disease is associated with decreased skeletal muscle aerobic capacity 
[11], slow to fast fibre type transition [12], and greater muscle fatigue 
[13]. Furthermore, the chronic hypoxia of altitude causes a decrease in 
human muscle aerobic capacity [14], and mitochondrial function [15] 
and chronic hypobaric hypoxia in rats increases limb muscle [16] and 
upper airway muscle [17] fatigue. Of interest, the diaphragm muscle is 
relatively tolerant of sustained hypoxia compared to upper airway and 
limb muscles [16-20]. Although in general we have seen only minor 
changes in muscle structure in response to intermittent hypoxia, the 
earlier studies, referred to above, of upper airway muscle morphology 
in the English bulldog [4] and in OSA patients [5] showed a fibre 
type transition from slow to fast for the dog and greater anaerobic 
capacity in OSA patients. Both of these effects would likely result in 
increased fatigability. Clearly, the reduced endurance caused by chronic 
intermittent hypoxia and asphyxia has important implications for OSA 
since greater fatigability of the upper airway muscles would make the 
upper airway more prone to collapse and create a positive feedback that 
would exacerbate the condition. 
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We have also looked at the mechanism of these effects. The fact 
that the changes occurred not just in respiratory muscles but also in 
limb muscles is evidence that these effects are not due to altered neural 
drive to the muscles caused by the hypoxia/asphyxia. In our model, 
there would be greater neural activation of the upper airway muscles 
and diaphragm caused by the hypoxic/asphyxic respiratory stimulus 
but this would not be true of the limb muscles. This suggests that the 
hypoxic/asphyxic effects are at the level of the muscles themselves. 
We were struck by the parallel between ischemia-reperfusion and 
intermittent hypoxia/asphyxia. Ischemia followed by reperfusion 
can cause tissue injury due to free radical generation caused by the 
re-oxygenation [21]. We hypothesised that the systemic hypoxia/re-
oxygenation of intermittent hypoxia causes oxidative stress i.e. the 
generation of reactive oxygen species that in turn cause the adverse 
effects on muscle function. We tested this hypothesis by exposing 
rats to intermittent hypoxia and to pro- and anti-oxidants. We found 
that even in normoxic rats, antioxidants improved force generation 
and endurance of upper airway muscles [22]. Furthermore, we found 
that chronic treatment with an antioxidant (a superoxide scavenger) 
prevented the reduction in force generation in upper airway muscle 
caused by chronic intermittent hypoxia and interestingly, this reduction 
in force could be reversed by acute administration of the antioxidant 
[23]. We also found that treatment with a pro-oxidant exacerbated 
the loss of endurance in upper airway muscle caused by chronic 
intermittent hypoxia [24]. However, we have found that the increase in 
upper airway muscle fatigability caused by chronic continuous hypoxia 
during early development was not prevented by antioxidant treatment 
[17], despite the fact that chronic continuous hypoxia has been shown 
to generate free radicals [25].
To summarise, it would appear that in general, both chronic 
sustained hypoxia and chronic intermittent hypoxia cause a reduction 
in skeletal muscle endurance. This maladaptive response has obvious 
relevance to conditions of intermittent hypoxia such as sleep apnoea 
and to conditions of continuous hypoxia such as respiratory disease 
in general since greater respiratory muscle fatigability is likely to 
exacerbate the underlying condition. Oxidative stress is implicated in 
the underlying mechanism since some of these deleterious effects can 
be prevented by treatment with free radical scavengers. 
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